Cryptic Insertions Of The Immunoglobulin Light Chain Enhancer Region Near CCND1 In T(11;14)-Negative Mantle Cell Lymphoma

dc.contributor.authorFuster, Carla
dc.contributor.authorMartín García, David
dc.contributor.authorBalagué, Olga
dc.contributor.authorNavarro, Alba
dc.contributor.authorNadeu Prat, Ferran
dc.contributor.authorCosta, Dolors
dc.contributor.authorPrieto, Miriam
dc.contributor.authorSalaverria Frigola, Itziar
dc.contributor.authorEspinet Solà, Blanca
dc.contributor.authorRivas Delgado, Alfredo
dc.contributor.authorTerol, Maria José
dc.contributor.authorGiné Soca, Eva
dc.contributor.authorForcada, Pilar
dc.contributor.authorAshton-Key, Margaret
dc.contributor.authorPuente, Xose S.
dc.contributor.authorSwerdlow, Steven H.
dc.contributor.authorBeà Bobet, Sílvia M.
dc.contributor.authorCampo Güerri, Elias
dc.date.accessioned2020-03-03T15:07:25Z
dc.date.available2020-03-03T15:07:25Z
dc.date.issued2019-01-01
dc.date.updated2020-01-08T09:21:10Z
dc.description.abstractCyclin D1+ mantle cell lymphoma (MCL) is molecularly characterized by the t(11;14)(q13;q32) or rearrangements of CCND1 gene with the immunoglobulin (IG) light chains.1,2 Most MCL can be diagnosed based on the characteristic pathologic features and cyclin D1 expression without the need for demonstrating the genetic translocation. However, in cases with atypical morphologic or phenotypic features other B-cell neoplasms that sometimes also have cyclin D1 positivity may be in the differential diagnosis.1 In these situations the detection of the CCND1 rearrangements may assist in the diagnosis since most other lymphomas do not carry translocations of the gene.3-7 A subset of plasma cell myelomas express cyclin D1 associated with the t(11;14) but are usually not in the differential diagnosis of MCL and are SOX11- negative.5 Nevertheless, there are occasional lymphoid neoplasms with MCL features in which cyclin D1 is strongly expressed without an apparent gene rearrangement using conventional cytogenetics or fluorescence in situ hybridization (FISH) with fusion or break-apart probes. The mechanisms of cyclin D1 overexpression in these cases are unclear and the MCL diagnosis may be questioned.
dc.format.extent27 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina5998414
dc.identifier.issn0390-6078
dc.identifier.pmid31753927
dc.identifier.urihttps://hdl.handle.net/2445/151846
dc.language.isoeng
dc.publisherFerrata Storti Foundation
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.3324/haematol.2019.237073
dc.relation.ispartofHaematologica, 2019
dc.relation.urihttps://doi.org/10.3324/haematol.2019.237073
dc.rights(c) Ferrata Storti Foundation, 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationMalaltia de Hodgkin
dc.subject.classificationLimfomes
dc.subject.otherHodgkin's disease
dc.subject.otherLymphomas
dc.titleCryptic Insertions Of The Immunoglobulin Light Chain Enhancer Region Near CCND1 In T(11;14)-Negative Mantle Cell Lymphoma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
12474_5998414_haematol.2019.237073.full.pdf
Mida:
1.64 MB
Format:
Adobe Portable Document Format